Terlipressin in Septic Shock in Cirrhosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Liver CirrhosisSeptic Shock
Interventions
DRUG

Terlipressin

Terlipressin 2-12 mg/24h intravenously in continuous infusion. Duration: until 24h after shock resolution.

DRUG

alpha adrenergic drugs

Dopamine (1-20 µg/Kg/min) and/or norepinephrine (0.05-4 µg/Kg/min) until shock resolution

Trial Locations (1)

08036

Hospital Clinic Barcelona, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT00628160 - Terlipressin in Septic Shock in Cirrhosis | Biotech Hunter | Biotech Hunter